Open tender · Germany · Cn Standard
Open house Arzneimittelrabattverträge Botulinumtoxin Typ A, Fertigarzneimittelbezeichnung Xeomin(R), ATC M03AX21
The work
Non-exclusive discount agreements for Botulinumtoxin Typ A (Xeomin(R)) are to be concluded with all interested pharmaceutical companies.
- Identical and non-negotiable discount agreements
- Submission of signed declaration of reliability, contract, and drug list
Key facts
- Contract period
- From 01.03.2025 to 28.02.2027
- Evaluation
- Selection based on submission of signed declaration of reliability
What it takes to qualify
Worth a closer look
- The tender document is for an open-house model, not a formal tender, and does not fall under procurement law.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zur Zuverlässigkeitmust be signed and submitted
- Vertragmust be signed and submitted
- Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"must be signed and submitted